ofloxacin has been researched along with IgA Vasculitis in 2 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
IgA Vasculitis: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Perna, CD | 1 |
| Vanni, S | 1 |
| Allegri, L | 1 |
| Manganelli, P | 1 |
| Buzio, C | 1 |
| Pace, JL | 1 |
| Gatt, P | 1 |
1 review available for ofloxacin and IgA Vasculitis
| Article | Year |
|---|---|
Severe glomerulonephritis and isolated ileitis in adult Henoch-Schoenlein purpura.
Topics: Anti-Infective Agents; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis; Humans; IgA | 2001 |
1 other study available for ofloxacin and IgA Vasculitis
| Article | Year |
|---|---|
Fatal vasculitis associated with ofloxacin.
Topics: Aged; Death, Sudden; Humans; IgA Vasculitis; Male; Ofloxacin; Respiratory Tract Infections | 1989 |